Cargando…
Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715427/ https://www.ncbi.nlm.nih.gov/pubmed/36115868 http://dx.doi.org/10.1038/s41409-022-01819-y |
| _version_ | 1784842447475441664 |
|---|---|
| author | Dimitrova, Dimana Kanakry, Jennifer A. |
| author_facet | Dimitrova, Dimana Kanakry, Jennifer A. |
| author_sort | Dimitrova, Dimana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9715427 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97154272022-12-03 Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning Dimitrova, Dimana Kanakry, Jennifer A. Bone Marrow Transplant Correspondence Nature Publishing Group UK 2022-09-17 2022 /pmc/articles/PMC9715427/ /pubmed/36115868 http://dx.doi.org/10.1038/s41409-022-01819-y Text en © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Dimitrova, Dimana Kanakry, Jennifer A. Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning |
| title | Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning |
| title_full | Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning |
| title_fullStr | Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning |
| title_full_unstemmed | Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning |
| title_short | Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning |
| title_sort | beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715427/ https://www.ncbi.nlm.nih.gov/pubmed/36115868 http://dx.doi.org/10.1038/s41409-022-01819-y |
| work_keys_str_mv | AT dimitrovadimana beyondfludarabinepentostatinpluscyclophosphamideareawelltoleratedalternativeinreducedintensityconditioning AT kanakryjennifera beyondfludarabinepentostatinpluscyclophosphamideareawelltoleratedalternativeinreducedintensityconditioning |